Clinical Trial Update: Annular Reshaping of the Mitral Valve for Patients With Mitral Regurgitation Using the Millipede IRIS System [NA]

View source ↗

Summary

This is an update on a completed clinical trial evaluating the Millipede IRIS System for annular reshaping to treat mitral regurgitation. The sponsor is Boston …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Mitral Valve Insufficiency | NA | Status: COMPLETED